We found that the ERCC2 Lys751Gln polymorphism was significantly associated with ovarian cancer, while the ERCC2 Asp312Asn and Arg156Arg polymorphisms did not exhibit any relationship with susceptibility to ovarian cancer. The gene discussed is ERCC2; the disease is ovarian carcinoma.